The synthesis and characterization of a new (E,E)-dioxime and its mono and heterotrinuclear complexes containing dioxadithiadiazamacrobicyclic moieties

A new (E,E)-dioxime (2Z,3Z)-1,4,7,8,15,16-hexahydro-9,14-(ethanothioethanothioethano)quinoxalino6,7-e] 4,7,1,10]benzodioxadiazacyclododecine-2,3,19,26-tetrone2,3-dioxime (H₂L) has been synthesized by reacting cyanogen-di-N-oxide with 2,3-diamino-6,7,14,15-tetrahydro-8,13-(ethanothioethanothioethano)dibenzob,h] 1,4,7,10]dioxadiazacyclodecine-17,24-dione (6). Mononuclear complexes (8, 9) of this ligand have been synthesized by reacting the vic-dioxime (H₂L) with NiCl₂ · 6H_2O and COCl₂ · 6H₂O respectively. The BF ₂ ⁺ capped cobalt(III) complex (10) of the new (E,E) vic-dioxime has been synthesized by using as precursor a hydrogen-bridged mononuclear cobalt(III) complex (9). The heterotrinuclear complex (11) has been prepared by reacting one mononuclear cobalt(III) complex (10) with Cu(MeCN)₄]PF₆. The new compounds were characterized by a combination of elemental analysis, ¹H- and ¹³C-n.m.r, i.r. and m.s. spectral data.